As shown in Figure 5D, the treatment of these reagents resulted in smaller tumor volumes by 6-fold in comparison with pSLTM-mCherry-tk-gRNA control (p < 0.01), and 5.3-fold with Cas9D10A-EGFP only control (p < 0.01). This evidence concerns the gene TKT and neoplasm.